Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G0NB
|
||||
Former ID |
DNC011510
|
||||
Drug Name |
2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533479] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H16N2
|
||||
Canonical SMILES |
CC(CC1=CC2=C(C=C1)NCC2)N
|
||||
InChI |
1S/C11H16N2/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-3,7-8,13H,4-6,12H2,1H3
|
||||
InChIKey |
YAVKNEHUAXPRSK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [533479] | |
Sodium-dependent dopamine transporter | Target Info | Inhibitor | [533479] | ||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
WikiPathways | Monoamine Transport | ||||
NRF2 pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
Dopaminergic Neurogenesis | |||||
Parkinsons Disease Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.